Clinical trial
Prospective Post Marketing Surveillance to Evaluate the Safety and Efficacy of Etanercept Under Usual Care Settings in Patients With Psoriatic Arthritis (PsA) Treated by Rheumatologists
NCT00293722 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Post Marketing Surveillance to Evaluate the Safety and Efficacy of Etanercept Under Usual Care Settings in Patients With Psoriatic Arthritis (PsA) Treated by Rheumatologists
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- February 28, 2013
- Enrollment
- 1,308 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.